Nanotherapeutics for Alzheimer’s disease (AD): Past, present and future

Author： Fazil Mohammad Baboota Sanjula Sahni Jasjeet K. Ali Javed

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.20, Iss.2, 2012-02, pp. : 97-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future directions in the treatment of Alzheimer’s disease

By Bullock Roger

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana Castro Ana

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Subcellular Injuries in Alzheimer’s Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease and related dementias:

By Williams M. Davis R.E.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 735-759

Informa Healthcare

Access to resources Recommend Favorite